Correlation Between Keros Therapeutics and Coya Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Coya Therapeutics, Common, you can compare the effects of market volatilities on Keros Therapeutics and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Coya Therapeutics,.

Diversification Opportunities for Keros Therapeutics and Coya Therapeutics,

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Keros and Coya is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Coya Therapeutics, go up and down completely randomly.

Pair Corralation between Keros Therapeutics and Coya Therapeutics,

Given the investment horizon of 90 days Keros Therapeutics is expected to generate 1.37 times more return on investment than Coya Therapeutics,. However, Keros Therapeutics is 1.37 times more volatile than Coya Therapeutics, Common. It trades about 0.08 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about -0.29 per unit of risk. If you would invest  6,488  in Keros Therapeutics on September 13, 2024 and sell it today you would earn a total of  377.00  from holding Keros Therapeutics or generate 5.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Keros Therapeutics  vs.  Coya Therapeutics, Common

 Performance 
       Timeline  
Keros Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Keros Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Keros Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Coya Therapeutics, Common 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Coya Therapeutics, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Coya Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Keros Therapeutics and Coya Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Keros Therapeutics and Coya Therapeutics,

The main advantage of trading using opposite Keros Therapeutics and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.
The idea behind Keros Therapeutics and Coya Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes